October saw the publication of two major reviews on inflammatory bowel disease and probiotics. Both underline the potential benefits of probiotics in this context, but call for additional research.
While the European Food Safety Authority (EFSA) recently rejected all probiotic health claims it reviewed, evidence in support of probiotics continues to grow. The October issue of the International Journal of Medical Microbiology provided an important contribution: it published two major reviews on the potential effect of probiotics on inflammatory bowel disease (IBD).
Want to finish this and read more complete articles?
Go to www.gutflora.org.
While the European Food Safety Authority (EFSA) recently rejected all probiotic health claims it reviewed, evidence in support of probiotics continues to grow. The October issue of the International Journal of Medical Microbiology provided an important contribution: it published two major reviews on the potential effect of probiotics on inflammatory bowel disease (IBD).
Want to finish this and read more complete articles?
Go to www.gutflora.org.
